{{Rsnum
|rsid=1534891
|Gene=CSNK1E
|Chromosome=22
|position=38299094
|Orientation=plus
|GMAF=0.09642
|Gene_s=CSNK1E,LOC100996460
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 82.3 | 17.7 | 0.0
| HCB | 79.6 | 19.0 | 1.5
| JPT | 87.6 | 12.4 | 0.0
| YRI | 93.9 | 6.1 | 0.0
| ASW | 89.5 | 10.5 | 0.0
| CHB | 79.6 | 19.0 | 1.5
| CHD | 76.1 | 22.0 | 1.8
| GIH | 66.3 | 29.7 | 4.0
| LWK | 95.5 | 4.5 | 0.0
| MEX | 89.7 | 10.3 | 0.0
| MKK | 77.6 | 20.5 | 1.9
| TSI | 71.6 | 26.5 | 2.0
| HapMapRevision=28
}}Along with [[rs6442925]] and [[rs534654]], this SNP, [[rs1534891]], is part of a 3-SNP (multi-locus) interaction that is associated with [[bipolar disorder]].{{PMID|18228528|OA=1
}}

{{PMID Auto
|PMID=18518925
|Title=Genetic susceptibility to heroin addiction: a candidate gene association study
|OA=1
}}

{{PMID Auto
|PMID=19934327
|Title=Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=19500151
|Title=Heroin addiction in African Americans: a hypothesis-driven association study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}